The cost-saving impact of Recombinant Insulin
Insulin infographics The cost-saving impact of Recombinant Insulin Solutions Realizing economic returns through improved productivity Explore the infographic below to see how the improved process performance achieved with Recombinant Insulin in cell culture, can translate into impressive cost savings for mAb production at both small and large production scales. Download the infographic in PDF format […]
Novo Nordisk Pharmatech Annual Report 2024
Our purpose – enabling better medicines, enabling better lives has for years centred around our commitment to bring forward pharmaceutical materials that enable our customers to produce better medicines. In 2024, we marked our 75th anniversary, an important milestone in our company’s history. What started as a small chemistry factory in Køge has become a […]
Where to meet us in 2025
Join us at the most important conferences in 2025. Our teams of experts will be there to answer all your questions, especially about our Recombinant Insulin and TrypsiNNex®. We will exhibit at: Biologics Manufacturing Asia at Marina Bay Sands Expo & Convention Centre in Singapore, March 12-13, 2025 World Vaccine Congress US at Walter E […]
Novo Nordisk Pharmatech is investing 1.5 billion Danish kroner in a new factory in Køge
In order to meet significantly higher demand from Novo Nordisk A/S for raw materials for the production of medicines to fight chronic diseases, Novo Nordisk Pharmatech A/S is building a new factory at Ådalen 16 in Køge. In March 2023, Novo Nordisk Pharmatech announced the purchase of a 47,000 m² site in Køge, with the […]
